Literature DB >> 25840582

Oral Infections, Metabolic Inflammation, Genetics, and Cardiometabolic Diseases.

S-J Janket1, H Javaheri2, L K Ackerson3, S Ayilavarapu2, J H Meurman4.   

Abstract

Although several epidemiologic studies reported plausible and potentially causal associations between oral infections and cardiometabolic diseases (CMDs), controversy still lingers. This might be due to unrecognized confounding from metabolic inflammation and genetics, both of which alter the immune responses of the host. Low-grade inflammation termed metainflammation is the hallmark of obesity, insulin resistance, type 2 diabetes, and CMDs. According to the common soil theory, the continuum of obesity to CMDs is the same pathology at different time points, and early metainflammations, such as hyperglycemia and obesity, display many adverse cardiometabolic characteristics. Consequently, adipose tissue is now considered a dynamic endocrine organ that expresses many proinflammatory cytokines such as TNF-α, IL-6, plasminogen activator inhibitor 1, and IL-1β. In metainflammation, IL-1β and reactive oxygen species are generated, and IL-1β is a pivotal molecule in the pathogenesis of CMDs. Note that the same cytokines expressed in metainflammation are also reported in oral infections. In metabolic inflammation and oral infections, the innate immune system is activated through pattern recognition receptors-which include transmembrane receptors such as toll-like receptors (TLRs), cytosolic receptors such as nucleotide-binding oligomerization domain-like receptors, and multiprotein complexes called inflammasome. In general, TLR-2s are presumed to recognize lipoteichoic acid of Gram-positive microbes-and TLR-4s, lipopolysaccharide of Gram-negative microbes-while nucleotide-binding oligomerization domain-like receptors detect both Gram-positive and Gram-negative peptidoglycans on the bacterial cell walls. However, a high-fat diet activates TLR-2s, and obesity activates TLR-4s and induces spontaneous increases in serum lipopolysaccharide levels (metabolic endotoxemia). Moreover, genetics controls lipid-related transcriptome and the differentiation of monocyte and macrophages. Additionally, genetics influences CMDs, and this creates a confounding relationship among oral infections, metainflammation, and genetics. Therefore, future studies must elucidate whether oral infections can increase the risk of CMDs independent of the aforementioned confounding factors. © International & American Associations for Dental Research 2015.

Entities:  

Keywords:  Fcγ; NLRP3 inflammasomes; NODs; TLRs; gut microbial dysbiosis; metabolic endotoxemia

Mesh:

Substances:

Year:  2015        PMID: 25840582     DOI: 10.1177/0022034515580795

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  12 in total

1.  Apical periodontitis and incident cardiovascular events in the Baltimore Longitudinal Study of Ageing.

Authors:  M S Gomes; F N Hugo; J B Hilgert; M Sant'Ana Filho; D M P Padilha; E M Simonsick; L Ferrucci; M A Reynolds
Journal:  Int Endod J       Date:  2015-06-11       Impact factor: 5.264

Review 2.  Myeloid-derived suppressor cells in obesity-associated periodontal disease: A conceptual model.

Authors:  Kyu Hwan Kwack; Victoria Maglaras; Ramkumar Thiyagarajan; Lixia Zhang; Keith L Kirkwood
Journal:  Periodontol 2000       Date:  2021-10       Impact factor: 12.239

3.  Vitamin D status affects the relationship between lipid profile and high-sensitivity C-reactive protein.

Authors:  Dan Jin; Dao-Min Zhu; Hong-Lin Hu; Meng-Nan Yao; Wan-Jun Yin; Rui-Xue Tao; Peng Zhu
Journal:  Nutr Metab (Lond)       Date:  2020-07-14       Impact factor: 4.169

4.  Polymicrobial Biofilm Studies: From Basic Science to Biofilm Control.

Authors:  Hubertine Me Willems; Zhenbo Xu; Brian M Peters
Journal:  Curr Oral Health Rep       Date:  2016-01-14

5.  Salivary pellets induce a pro-inflammatory response involving the TLR4-NF-kB pathway in gingival fibroblasts.

Authors:  Heinz-Dieter H-D Müller; Barbara B Cvikl; Adrian A Lussi; Reinhard R Gruber
Journal:  BMC Oral Health       Date:  2016-07-08       Impact factor: 2.757

Review 6.  NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy.

Authors:  Beibei Luo; Feng Huang; Yanli Liu; Yiying Liang; Zhe Wei; Honghong Ke; Zhiyu Zeng; Weiqiang Huang; Yan He
Journal:  Front Physiol       Date:  2017-07-25       Impact factor: 4.566

7.  Association between Frequency of Toothbrushing and Metabolic Syndrome among Adolescents: A 5-Year Follow-Up Study.

Authors:  Jagan Kumar Baskaradoss; Mary Tavares; Fahd Al-Mulla; Ebaa Al-Ozairi; Mohamed Abu-Farha; Saadoun Bin-Hasan; Aishah Alsumait; Sriraman Devarajan; Hend Alqaderi
Journal:  Int J Environ Res Public Health       Date:  2022-01-03       Impact factor: 3.390

8.  Comparison of periodontal parameters between patients with ischemic and dilative cardiomyopathy.

Authors:  Jens Garbade; Gerhard Schmalz; Dirk Ziebolz; Christian Binner; Florentine Reuschel; Mirjam Eisner; Justus Wagner; Tanja Kottmann; Christian D Etz; Sven Lehmann
Journal:  BMC Cardiovasc Disord       Date:  2021-06-16       Impact factor: 2.298

Review 9.  On the Road to Accurate Biomarkers for Cardiometabolic Diseases by Integrating Precision and Gender Medicine Approaches.

Authors:  Letizia Scola; Rosa Maria Giarratana; Salvatore Torre; Vincenzo Argano; Domenico Lio; Carmela Rita Balistreri
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

Review 10.  NLRP3 Inflammasome Biomarker-Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome.

Authors:  Andra-Iulia Suceveanu; Laura Mazilu; Niki Katsiki; Irinel Parepa; Felix Voinea; Anca Pantea-Stoian; Manfredi Rizzo; Florin Botea; Vlad Herlea; Dragos Serban; Adrian-Paul Suceveanu
Journal:  Metabolites       Date:  2020-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.